Wolverine Trading, LLC Astrazeneca PLC Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

28 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $567,358 - $648,388	7,400 Added 14.04%	60,100 $4.68 Million
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $1.2 Million - $1.45 Million	18,000 Added 51.87%	52,700 $4.11 Million
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $469,931 - $535,689	-7,700 Reduced 18.16%	34,700 $2.35 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $12.8 Million - $14.3 Million	-207,100 Reduced 83.01%	42,400 $2.86 Million
Q3 2023 Nov 15, 2023	BUY	$64.85 - $71.7 $12.7 Million - $14 Million	195,500 Added 362.04%	249,500 $16.9 Million
Q2 2023 Aug 23, 2023	SELL	$69.91 - $75.81 $3.52 Million - $3.82 Million	-50,400 Reduced 48.28%	54,000 $3.86 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $3.2 Million - $3.62 Million	50,600 Added 94.05%	104,400 $7.22 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $86,736 - $112,704	1,600 Added 3.07%	53,800 $3.65 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $970,266 - $2.48 Million	-18,300 Reduced 25.96%	52,200 $2.87 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $207,410 - $248,990	-3,500 Reduced 4.73%	70,500 $4.73 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $4.12 Million - $4.97 Million	74,000 New	74,000 $4.97 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $9.96 Million - $11.8 Million	-184,400 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $10.2 Million - $11.2 Million	184,400 New	184,400 $11 Million
Q2 2021 Aug 06, 2021	SELL	$48.42 - $60.18 $7.75 Million - $9.63 Million	-160,000 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$47.16 - $54.44 $3.33 Million - $3.84 Million	-70,600 Reduced 30.62%	160,000 $8 Million
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $6.38 Million - $7.62 Million	131,400 Added 132.46%	230,600 $11.6 Million
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $1.26 Million - $1.45 Million	-23,800 Reduced 19.35%	99,200 $5.47 Million
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $3.17 Million - $4.07 Million	73,600 Added 148.99%	123,000 $6.51 Million
Q1 2020 May 11, 2020	SELL	$37.79 - $51.33 $200,287 - $272,049	-5,300 Reduced 9.69%	49,400 $2.2 Million
Q4 2019 Feb 12, 2020	SELL	$42.46 - $50.46 $1.2 Million - $1.43 Million	-28,300 Reduced 34.1%	54,700 $2.74 Million
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $437,308 - $495,623	10,900 Added 15.12%	83,000 $3.76 Million
Q2 2019 Aug 20, 2019	BUY	$37.28 - $41.68 $2.69 Million - $3.01 Million	72,100 New	72,100 $2.98 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $2.67 Million - $3.24 Million	-75,300 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $1.63 Million - $1.83 Million	-44,100 Reduced 36.93%	75,300 $2.84 Million
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $1.66 Million - $1.9 Million	47,800 Added 66.76%	119,400 $4.73 Million
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $2.36 Million - $2.62 Million	71,600 New	71,600 $2.5 Million
Q4 2017 Feb 14, 2018	SELL	$32.09 - $34.78 $2.69 Million - $2.91 Million	-83,800 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$28.96 - $34.0 $2.43 Million - $2.85 Million	83,800	83,800 $2.84 Million

Others Institutions Holding AZN

# of Institutions

1,359

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.13 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.76 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.44 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.42 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.3M
Shares

$1.27 Billion
0.43% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account